ProTexase Therapeutics, Inc.

Biotechnology company · Saint Louis, Missouri, United States

ProTexase Therapeutics, Inc. is a biotechnology company headquartered in Saint Louis, Missouri, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $599,952 in total, most recently in 2019.

protexase.comProfile compiled from public records. Is this your company? Request a correction or update

ProTexase Therapeutics at a glance

Typebiotechnology company

HeadquartersSaint Louis, Missouri, United States

Employees (self-reported, 2019)2

What does ProTexase Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $599,952 in total (2018 to 2019). NIH funding came from the National Cancer Institute.

Frequently asked questions about ProTexase Therapeutics

Where is ProTexase Therapeutics headquartered?

ProTexase Therapeutics, Inc. is headquartered in Saint Louis, Missouri, United States.

What does ProTexase Therapeutics do?

ProTexase Therapeutics, Inc. is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences